# Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers

> **NCT01989533** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 62 (actual)

## Conditions studied

- Vaccine Response

## Interventions

- **BIOLOGICAL:** Ad4-mgag
- **BIOLOGICAL:** Ad4-EnvC150
- **BIOLOGICAL:** gp 120 Protein Boost

## Key facts

- **NCT ID:** NCT01989533
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-19
- **Primary completion:** 2019-04-08
- **Final completion:** 2019-04-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01989533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01989533, "Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01989533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*